Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALM1 | P0DP23 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.32 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.32 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.32 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10791795 | 0.87 | CALM1 (0.46) | CALM1LOXL2ALDH1A1POLBMEN1 | |
| SCHEMBL6557214 | 0.80 | CALM1 (0.52) | CALM1PARP1LOXL2ALDH1A1POLB | |
| Hydrochloric Acid SCHEMBL2873364 | 0.78 | CALM1 (0.50) | CALM1PARP1LOXL2ALDH1A1POLB | |
| SCHEMBL29644323 | 0.77 | MAOB (0.38) | CALM1ALDH1A1MEN1LMNAGAA | |
| SCHEMBL29206317 | 0.77 | MAOB (0.38) | CALM1ALDH1A1MEN1LMNAGAA | |
| SCHEMBL7036784 | 0.76 | GABRA1 (0.40) | CALM1ALDH1A1MEN1LMNAMAPT | |
| Formaldehyde SCHEMBL28303102 | 0.76 | TRIM24 (0.41) | CALM1PARP1ALDH1A1POLBMEN1 | |
| SCHEMBL5598298 | 0.76 | CYP3A4 (0.34) | PARP1ALDH1A1 | |
| SCHEMBL21987780 | 0.76 | IMPDH2 (0.40) | ALDH1A1 | |
| SCHEMBL20767517 | 0.75 | FAAH (0.43) | ALDH1A1MEN1KMT2AMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3129464-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | The Trustees of Columbia University in the City of New York (US) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015157664-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-10-15 | — | — | WO | disclosed |
| WO-2011087521-A1 | CHEMILUMINESCENT DYES AND DYE-STAINED PARTICLES | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-07-21 | — | — | WO | disclosed |
| EP-0930844-B8 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | LANTHEUS MEDICAL IMAGING INC (US) | 2008-11-26 | — | — | EP | disclosed |
| EP-0959908-A4 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2002-11-20 | — | — | EP | disclosed |
| EP-0988061-A4 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-0930844-A4 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP (US) | 2002-03-13 | — | — | EP | disclosed |
| EP-1146911-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-2000045856-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2000-08-10 | — | — | WO | disclosed |
| EP-0988061-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-03-29 | — | — | EP | disclosed |
| EP-0831932-A4 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2000-01-12 | — | — | EP | disclosed |
| EP-0959908-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-12-01 | — | — | EP | disclosed |
| EP-0930844-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1999-07-28 | — | — | EP | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998050040-A1 | NOVEL LIPID SOLUBLE STEROID PRODRUGS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998042384-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | disclosed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997048337-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |